During extrauterine life, insulin-like growth factors (IGFs) circulate in a ternary serum complex with one IGF-binding protein-3 (IGFBP-3) or IGFBP-5 protein and with a single acid-labile subunit (ALS). GH increases levels of this ternary complex; in mice, this effect is achieved in part by the ability of GH to stimulate mouse ALS (mALS) transcription through an interferon-␥-activated sequencelike element (GLE) in the mALS promoter. To begin studying how GH regulates human ALS (hALS) gene expression, we cloned the hALS gene and found that it spans approximately 3.3 kb of DNA at chromosomal region 16p13.3. The hALS gene has two exons separated by a 1235-bp intron, which is found at the identical site in rat and mouse ALS genes. Sequence analysis reveals that the hALS 5Ј-flanking sequence is homologous to the mALS promoter, and that the GHresponsive GLE in the mALS promoter is conserved in both sequence and location in the hALS gene. The region spanning from Ϫ755 to Ϫ4 bp 5Ј to the hALS ATG translation start codon directs expression of a luciferase reporter gene in primary rat hepatocytes, and GH increases reporter expression in the presence of the native, but not a mutant, GLE in the hALS promoter. These data suggest that GH stimulates hALS and mALS gene expression by a similar mechanism, which involves at least in part a conserved GLE in the ALS promoter. (Endocrinology 141: [833][834][835][836][837][838] 2000) 
ALS genes. Sequence analysis reveals that the hALS 5Ј-flanking sequence is homologous to the mALS promoter, and that the GHresponsive GLE in the mALS promoter is conserved in both sequence and location in the hALS gene. The region spanning from Ϫ755 to Ϫ4 bp 5Ј to the hALS ATG translation start codon directs expression of a luciferase reporter gene in primary rat hepatocytes, and GH increases reporter expression in the presence of the native, but not a mutant, GLE in the hALS promoter. These data suggest that GH stimulates hALS and mALS gene expression by a similar mechanism, which involves at least in part a conserved GLE in the ALS promoter. I NSULIN-LIKE growth factor I (IGF-I) and IGF-II are approximately 7.5-kDa proteins that exhibit mitogenic, metabolic, differentiative, chemotactic, and antiapoptotic effects on many tissues and cell types (1, 2) . IGFs often confer their effects in an autocrine/paracrine manner (1, 2) . After birth, however, circulating IGFs also appear to be biologically important, as many effects of GH are mediated by IGF-I (1-3).
IGFs circulate in serum and other body fluids at higher molecular mass, tightly bound by a family of at least six IGF-binding proteins (IGFBPs) (4 -6) . During extrauterine life, most IGFs circulate at about 150 kDa in a ternary complex of one IGF peptide, one IGFBP-3 or IGFBP-5 protein, and an 86-kDa acid-labile subunit (ALS) (6 -9) .
The human ALS (hALS) complementary DNA (cDNA) sequence predicts a protein with 18 -20 leucine-rich repeats of 24 amino acids (10) ; also present are 7 asparagine-linked glycosylation sites, which are important for binding of ALS to IGFBP-3 (11) . Binding of the IGFBP-3/IGF-I complex with ALS to form the serum ternary complex greatly prolongs the circulating half-life of IGF-I (12) . This is in part due to the decreased ability of ternary complexes to cross the capillary endothelial barrier; also, binding of ALS to IGFBP-3 or -5 may prevent proteases from binding to and degrading these IGFBPs, with subsequent release of IGFs to tissues (1, 2, (13) (14) (15) . In either case, IGFs in ternary complexes are not readily bioavailable; whether these complexes serve primarily as an IGF reservoir or as a way to prevent unwanted insulin-like metabolic effects of IGF peptides (1, 2) is unclear.
ALS is expressed in a tissue-specific pattern, with synthesis confined almost exclusively to parenchymal cells of the postnatal liver (16, 17) . GH treatment increases ALS protein levels in serum and in medium conditioned by primary rat hepatocytes in vitro; these increases result from the ability of GH to induce ALS messenger RNA (mRNA) levels in rat hepatocytes in vitro and in vivo (18 -23) . GH stimulation of ALS mRNA levels in liver of hypophysectomized rats is mediated at the level of ALS gene transcription (21) .
The chromosomal genes for mouse ALS (mALS) and rat ALS (rALS) have been cloned (24, 25) . They share a simple organization with the protein-coding and 3Ј-untranslated regions contained in two exons separated by a single intron, which is identically positioned in the ALS genes from these two species. The 5Ј-flanking sequences in these two ALS genes are also quite similar. In the mALS gene, approximately 2 kb of the 5Ј-flanking region demonstrated promoter activity when transfected into rat H4-II-E hepatoma cells or primary hepatocytes, and GH significantly increased promoter activity (21, 24, 26) . GH responsiveness of the mALS promoter has been mapped to a single DNA motif resembling an interferon-␥-activated sequence-like element (GLE) (26) . The present studies characterize the location and organization of the hALS chromosomal gene and show that the hALS and mALS promoter regions are homologous. These studies also demonstrate that the GH-responsive GLE is 100% conserved in and is able to confer GH stimulation to the hALS promoter.
Materials and Methods

General methods
Oligonucleotides used for sequencing, site-directed mutagenesis, and PCR amplifications were synthesized by either Ana-Gen Technologies (Palo Alto, CA) or the Child Health Research Center Core Facility at Baylor College of Medicine (Houston, TX). All native and mutant sequences and construct orientations were determined by DNA sequencing either using Sequenase (U.S. Biochemical Corp., Cleveland, OH) in the dideoxy chain termination method (27) or by dye terminator automated sequencing performed by the Child Health Research Center Core Facility using an ABI/Perkin-Elmer Corp. automated sequencer (Palo Alto, CA).
Isolation of hALS cDNA
One microgram of human liver total RNA (CLONTECH Laboratories, Inc., Palo Alto, CA) was reverse transcribed using random hexamer priming and SuperScript II (Life Technologies, Inc./BRL, Rockville, MD). This material served as template for oligonucleotides primers 5Ј-CTTCCTCAAGGACAACGG-3Ј and 5Ј-TTCCTGAGGCTGAGG-TAGC-3Ј in a PCR amplification using Taq polymerase (Life Technologies, Inc./BRL), resulting in a 300-bp hALS DNA fragment spanning from 1245-1544 bp of the published hALS cDNA sequence (10) . This amplicon was visualized by 8% PAGE, cut from the gel, eluted, ethanol precipitated, and then amplified in a second round of PCR. The purified DNA product served as template for 32 P labeling of this 300-bp fragment using the same oligonucleotide primers and PCR conditions; labeled DNA was then used to screen a Unizap human liver cDNA library (Stratagene, La Jolla, CA) as described previously (28) . As no full-length hALS cDNA was isolated, a SmaI/Bsu36I fragment (1578 -1898 bp of the published sequence) from a partial hALS cDNA was 32 P labeled and used to screen a human liver 5Ј-STRETCH PLUS cDNA library (CLON-TECH Laboratories, Inc.). A 2-kb hALS cDNA was isolated and subcloned into pSP73 using EcoRI. This cDNA, spanning from 30 -2039 bp of the hALS sequence, was subcloned into M13mp19 at the EcoRI site. Oligonucleotide 5Ј-TACCGAGCTCGAATTCCATGGCCCTGAGGAA-AGGAGGCCTGGCCCTG GCGCTGCTGCTGCTGT-3Ј was used to introduce the missing 29 bp of hALS coding sequence by site-directed mutagenesis using the Kunkel method, as described previously (29) . The full-length hALS cDNA was subcloned into pBluescript II SK Ϫ (Stratagene) at the EcoRI site, creating phALS.
Isolation of a human ALS genomic clone
A 1.5-kb SacII/EcoRI fragment spanning from 570-2039 bp of the hALS sequence was labeled with 32 P and used to screen a human placental genomic library constructed in phage EMBL 3 (CLONTECH Laboratories, Inc.) as described previously (30) . A single hALS clone was plaque purified, cleaved with several restriction endonucleases, and transferred to filters. The filters were prehybridized, hybridized, and autoradiographed as described previously (30), using both the 1.5-kb SacII/EcoRI 3Ј-hALS cDNA fragment, and a 5Ј-EcoRI/SacII fragment spanning from 1-575 bp of the hALS cDNA sequence, as 32 P-labeled probes. A 4.8-kb KpnI/SacII fragment of the hALS clone, which hybridized with the 5Ј-but not the 3Ј-hALS cDNA probe, was then subcloned into pBluescript II SK Ϫ at KpnI/SacII, creating pg5hALS. Partial DNA sequencing of this fragment revealed that the 3Ј-end was identical to a region of the hALS cDNA extending to the SacII site at bp 575 of the published hALS sequence (10) . To further characterize the 3Ј-end of the hALS gene, the hALS DNA was used as template for oligonucleotide primers 5Ј-CTCAACCTCGGCTGGAATAG-3Ј and 5Ј-CGATTGCCTT-TGCCTTTAATTG-3Ј, which were used to PCR amplify the 3Ј-region of the hALS gene spanning from to 523-1998 bp of the published hALS cDNA sequence. This PCR product was subcloned into pCR2.1 (Invitrogen, San Diego, CA), creating pg3hALS.
Fluorescence in situ hybridization
The 4.8-kb KpnI/SacII fragment of the hALS clone was used to probe standard metaphase spreads obtained from the peripheral blood lymphocytes of a human male donor. Details of probe labeling, chromosome identification, fluorescence in situ hybridization procedures, and digital imaging and processing have been reported previously (31) .
Plasmid construction A 1.4-kb fragment containing the ALS promoter region was released from pg5hALS with SalI (5Ј)/SphI (3Ј), subcloned into M13mp19 at these sites, and sequenced. A 0.8-kb fragment containing the proximal hALS promoter was released from m13mp19 with NcoI (5Ј)/BamHI (3Ј) and subcloned into the HindIII site 5Ј to the luciferase reporter gene in pGL3-Basic (Promega Corp., Madison, WI), creating p755hALS. A GLE spanning from 667-675 bp 5Ј to the hALS ATG translation start codon, which is 100% conserved in the mALS gene and confers GH stimulation to the mALS promoter (26) , was mutated using oligonucleotide 5Ј-TGCAGCCCTGCCAG GCAACGTATCGT-GAGGCTGGGGGCGGGGC-3Ј. The 0.8-kb hALS promoter fragment containing the mutated GLE was released from m13mp19 with NcoI (5Ј)/BamHI (3Ј) and subcloned into the HindIII site in pGL3-Basic, creating p755hALSmGLE. The construction of p703WT, which contains the proximal 703 bp of the mALS promoter 5Ј to the luciferase reporter gene in pGL3-Basic, has been described previously (26) .
Cell culture and DNA transfection
Primary hepatocytes, isolated from male Sprague Dawley rats (250 -300 g) by procedures approved by the Cornell University Institutional animal care and use committee, were plated in six-well plates at a density of 1 ϫ 10 6 cells/well and maintained as described previously (26) . Hepatocytes were washed twice with serum-free modified William's E medium (MWEM) and then transfected for 14 h with a 1-ml solution of serum-free MWEM containing 1.2 g luciferase plasmid, 0.018 g pCMV-SEAP, which controlled for transfection efficiency, and 15 g lipofectin (Life Technologies, Inc./BRL). After transfection, cells were cultured for 48 h in MWEM in the presence or absence of 100 ng/ml bovine GH (bGH); for the first 24 h, MWEM was supplemented with Matrigel (Becton Dickinson and Co., Bedford, MA). At the end of this 48-h period, medium was assayed for luciferase activity as described previously (26) and for secreted alkaline phosphatase by chemiluminescence following the recommendations of the manufacturer (Tropix, Bedford, MA).
Expression of hALS
Plasmid pKG3226 contains the human ␤-actin promoter, simian virus 40 polyadenylation signal, and neomycin phosphotransferase resistance gene (32) . Full-length hALS cDNA was released from phALS and subcloned into pKG3226 with EcoRI; the resulting expression vector, pKG3226/hALS, was stably transfected into Chinese hamster ovary (CHO)-K1 cells as described previously (14) . Cells were incubated in serum-free McCoy's 5A medium, and the medium was then screened for hALS expression by immunoblot as described previously (14), using a 1:7500 dilution of goat antihuman ALS antibody (Diagnostics Systems Laboratories, Inc., Webster, TX). ALS partially purified from human serum on a hIGFBP-3 antibody column (14) was used as a positive control on the immunoblot.
Results
Isolation of a hALS cDNA
A nearly full-length hALS cDNA was isolated from a human liver cDNA library as described in Materials and Methods. It spanned from 30 -2039 bp of the published hALS cDNA and was identical to the published sequence (10) . After the missing 29 bp of 5Ј-hALS coding sequence were added by site-directed mutagenesis, the full-length hALS cDNA was inserted into eukaryotic expression vector pKG3226 and transfected into CHO-K1 cells. Cells stably transfected with pKG3226/hALS expressed an approximately 85-kDa protein that comigrated with partially purified hALS and was recognized by hALS antiserum (Fig. 1) ; this protein was not expressed by cells transfected with pKG3226 alone (data not shown).
Isolation and characterization of the hALS gene
A single hALS genomic clone was isolated by screening 3 ϫ 10 5 plaques from a human placental genomic library using both 5Ј-and 3Ј-hALS cDNA probes. Southern blotting of this plaque-purified hALS clone identified a 4.8-kb KpnI/ SacII hALS fragment, which was recognized by the 5Ј-, but not the 3Ј-, hALS cDNA probe. DNA sequencing confirmed that the 3Ј-end of this 4.8-kb genomic fragment was identical to a region of the hALS cDNA spanning from bp 17 to the SacII site at bp 575 of the published hALS sequence (10) .
Partial sequencing of the 4.8-kb KpnI/SacII genomic fragment revealed a single 1235-bp intron beginning 17 bp 3Ј to the ATG translation start codon. To determine whether additional 3Ј-introns were present in the hALS gene, oligonucleotide primers were designed to PCR amplify the region of the hALS cDNA that spans from 532-1998 bp and contains the polyadenylation signal. These primers amplified an identical 1466-bp PCR product when either hALS or the hALS cDNA served as template, thus confirming the absence of additional introns in the hALS gene. The organization of the hALS gene is shown in Fig. 2 .
Chromosomal localization of the hALS gene
Fluorescence in situ hybridization revealed that for all analyzed metaphases, only chromosome 16 hybridized with the 4.8-kb KpnI/SacII fragment of hALS (Fig. 3) . Q-banding placed the ALS gene on the short arm at p13.3 (data not shown).
hALS gene organization 5Ј to the ATG translation start codon
DNA sequencing of pg5hALS established the proximal 1398 bp of the hALS gene 5Ј to the ATG translation start codon. As shown in Fig. 4 , this region is homologous to the comparable region of the mALS gene that contains the mALS promoter (24) and to the comparable region of the rALS gene (25) . In particular, this region of the hALS gene contains the GLE 5Ј-TTCCTAGAA-3Ј, spanning from Ϫ675 to Ϫ667 bp 5Ј to the ATG translation start codon, which is conserved in sequence and location in the mALS and rALS 5Ј-flanking regions. In the mALS gene, this GLE confers the stimulatory effect of GH on mALS promoter activity (26) .
Identification of a GH-responsive element in the hALS promoter
To determine whether the hALS promoter is responsive to GH, the region spanning from Ϫ755 to Ϫ4 bp 5Ј to the hALS ATG translation start codon was placed 5Ј to the luciferase reporter gene, creating p755hALS. When primary rat hepatocytes were transiently transfected with p755hALS and incubated with or without 100 ng/ml bGH for 48 h, luciferase values rose 45% in the presence of bGH (Fig. 5) . When hepatocytes were transiently transfected with p755hALSmGLE, which is identical to p755hALS except that the potentially GH-responsive GLE in the hALS promoter is replaced with the sequence 5Ј-ACGTATCGT-3Ј, luciferase values were comparable in cells incubated with or without bGH. In hepatocytes transiently transfected with the positive control plasmid p703WT, which contains the proximal 703 bp of the mALS promoter 5Ј to the luciferase reporter gene, bGH stimulated p703WT activity by 167% (data not shown).
Discussion
The hALS gene contains two exons that span about 3.3 kb of DNA. The intron/exon splice junctions of the single hALS intron conform to consensus sequences derived from other vertebrate genes (33) and are identical in location to those of the rALS and mALS genes (24, 25) . Although the single hALS intron is similar in size to the mALS and rALS introns, it shares only about 40% nucleotide identity with these rodent introns and contains no regions of high similarity that might suggest an important regulatory region. The hALS cDNA and gene exon sequences were identical to the published hALS cDNA sequence (10) .
The hALS gene is located on chromosomal region 16p13.3 near the ␣-globin gene complex. Deletions of the 16p13.3 region are described in eight individuals with ␣-thalassemia and mild to moderate mental retardation (34) . In these cases, ␣-thalassemia results from failure of the individual to inherit a normal ␣-globin allele from one parent. In addition to ␣-thalassemia and mental retardation, a variety of dysmorphic features are also described in these individuals. In general, their clinical phenotype is nonspecific, and short stature was present in only two of the eight patients. In mice, growth failure occurs with targeted inactivation of both, but not one, of the ALS alleles (Boisclair, Y. R., unpublished results). Thus, growth failure is unlikely to be a part of the ␣-thalassemia/ mental retardation phenotype, as these individuals have at least one ALS allele.
Although the rALS and mALS 5Ј-flanking regions share 87% nucleotide identity over the first 1318 bp of the mouse sequence, they apparently differ in the locations of their transcription start sites (24, 25) . In the rALS gene, the major transcription start sites were located 447, 472, and 505 bp 5Ј to the ATG translation start codon. In contrast, the transcription start sites in the mALS gene clustered between 10 -161 bp 5Ј to the ATG translation start codon, a region that is entirely contained within a known rALS cDNA sequence. This variability may be due to the fact that consensus TATA sequences, initiator sequences, or GC boxes, which serve to target the site of transcription initiation in most genes, are not conserved in the 5Ј-flanking regions of the ALS genes (24, 25) . Transcription start sites were not mapped in the hALS gene due to lack of sufficient intact human liver RNA and to lack of human cell lines expressing ALS. However, comparing the known size of hALS mRNA transcripts in liver with the hALS cDNA sequence (10) suggests that hALS transcription start sites more closely approximate those in the mALS than the rALS gene.
Although rALS and mALS 5Ј-flanking regions are highly similar, they share only 51% and 47% nucleotide identity, respectively, with the proximal 1398-bp region of the hALS gene. However, the sequence spanning from Ϫ688 to Ϫ625 bp of the hALS 5Ј-flanking region is 81% and 77% conserved in the rALS and mALS 5Ј-flanking regions, respectively. The GLE that confers GH stimulation to the mALS promoter is present in this region of the mALS gene and is 100% conserved in the rALS and hALS genes (24 -26) , suggesting that this GLE participates in GH stimulation of hALS and rALS transcription. This hypothesis is supported by studies presented here, which show that GH does indeed stimulate the activity of the hALS promoter construct containing the native, but not the mutant, GLE. The effect of GH on mALS promoter activity appears to be mediated by members of the signal transducers and activators of transcription (STAT) protein family, STAT5a and STAT5b, which bind directly to this GLE in a GH-dependent fashion (26, 35) . Considering that the GLE is 100% conserved in the hALS gene, it seems likely that STAT5a and STAT5b also confer GH stimulation to the hALS promoter. Although this hypothesis has not been tested, the data presented here provide strong evidence that GH uses a common mechanism to stimulate transcription of human and mouse ALS genes.
The significance of GH's ability to more potently stimulate the mALS than the hALS promoter is unclear. Certainly, the transcriptional activity of STAT5 isoforms can be affected by the nature of surrounding DNA sequence (36 -38) . This suggests that although the GLE is necessary for GH stimulation of hALS and mALS promoter activity, nearby DNA elements and the proteins that they bind modulate STAT5 transcriptional activation and account for the differences in GH-stim- Comparison of 5Ј-flanking regions among the human, rat, and mouse ALS genes. DNA sequence from the human ALS 5Ј-flanking region was aligned with homologous regions from rat (25) and mouse (24) ALS genes using the algorithm of Smith and Waterman (30) . Gaps in any sequence are represented by a dot. Nucleotides conserved between the hALS sequence and either the rALS or mALS sequence are represented by a dash. Numbers on the left refer to the distance, in base pairs, 5Ј (negative) to the A of the ATG translation start codon; for each ALS gene, this ATG codon is shown as the last 3 bp of sequence. The GH-responsive GLE spanning Ϫ675 to Ϫ667 bp of the hALS sequence is underlined. ulated activity of the mALS and hALS promoters. Based on these considerations, future studies will focus on identifying the proteins that interact to confer GH stimulation of hALS transcription.
FIG. 5. Effect of GH on hALS promoter activity. DNA fragments spanning from Ϫ755 to Ϫ4 bp 5Ј to the hALS ATG translation start codon and containing either the native or mutant GLE were placed 5Ј to the luciferase reporter gene to create either p755hALS or p755hALSmGLE, respectively. These constructs were transiently transfected into primary rat hepatocytes and then cultured in serumfree medium in the presence or absence of 100 ng/ml bGH, as described in Materials and Methods. After 48 h, medium from each plate was assayed for luciferase activity. Activity of plasmids incubated without bGH were arbitrarily set at 100%; all values are presented as the mean Ϯ SD and represent the results of two independent experiments performed in triplicate.
